Literature DB >> 7559804

Protein kinase A regulates the degradation rate of Rs acetylcholine receptors.

R Xu1, M M Salpeter.   

Abstract

Acetylcholine receptors at the neuromuscular junction of innervated vertebrate muscle (called Rs AChRs) have a stable degradation rate (t1/2 approximately 8-12 days) which accelerates after denervation to a half-life of approximately 3 days, but can be restabilized by reinnervation or by cAMP. We examined the mechanism by which cAMP regulates the Rs degradation rate. When dibutyryl cAMP (DB-cAMP) was applied to denervated mouse diaphragms in organ culture, it stabilized the accelerated degradation rate of the Rs. We found that this stabilization is reversible upon removal of the DB-cAMP, is cAMP specific and is mediated by intracellular cAMP. A major observation of this study is that the cAMP-induced stabilization of Rs AChRs is via protein kinase A (PKA), since H89, a PKA inhibitor, blocked the DB-cAMP induced stabilization of Rs, and H85, an analog of H89, which does not inhibit PKA but does inhibit other kinases as efficiently as H89, did not prevent the DB-cAMP-induced stabilization of Rs degradation. These results suggest that the cAMP messenger system via a PKA-dependent pathway could be among the mechanisms whereby the nerve regulates AChR degradation.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7559804     DOI: 10.1002/jcp.1041650105

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  10 in total

1.  Metabolic stabilization of muscle nicotinic acetylcholine receptor by rapsyn.

Authors:  Z Z Wang; A Mathias; M Gautam; Z W Hall
Journal:  J Neurosci       Date:  1999-03-15       Impact factor: 6.167

2.  Neural agrin controls acetylcholine receptor stability in skeletal muscle fibers.

Authors:  G Bezakova; I Rabben; I Sefland; G Fumagalli; T Lømo
Journal:  Proc Natl Acad Sci U S A       Date:  2001-08-07       Impact factor: 11.205

3.  Beneficial effects of albuterol in congenital endplate acetylcholinesterase deficiency and Dok-7 myasthenia.

Authors:  Teerin Liewluck; Duygu Selcen; Andrew G Engel
Journal:  Muscle Nerve       Date:  2011-09-23       Impact factor: 3.217

Review 4.  Cellular trafficking of nicotinic acetylcholine receptors.

Authors:  Paul A St John
Journal:  Acta Pharmacol Sin       Date:  2009-06       Impact factor: 6.150

5.  NHERF3 is necessary for Escherichia coli heat-stable enterotoxin-induced inhibition of NHE3: differences in signaling in mouse small intestine and Caco-2 cells.

Authors:  Tiane Chen; Ruxian Lin; Leela Avula; Rafiquel Sarker; Jianbo Yang; Boyoung Cha; Chung Ming Tse; George McNamara; Ursula Seidler; Scott Waldman; Adam Snook; Marcel J C Bijvelds; Hugo R de Jonge; Xuhang Li; Mark Donowitz
Journal:  Am J Physiol Cell Physiol       Date:  2019-07-31       Impact factor: 4.249

6.  Acetylcholine receptors in innervated muscles of dystrophic mdx mice degrade as after denervation.

Authors:  R Xu; M M Salpeter
Journal:  J Neurosci       Date:  1997-11-01       Impact factor: 6.167

7.  Cyclic GMP kinase II (cGKII) inhibits NHE3 by altering its trafficking and phosphorylating NHE3 at three required sites: identification of a multifunctional phosphorylation site.

Authors:  Tiane Chen; Hetal S Kocinsky; Boyoung Cha; Rakhilya Murtazina; Jianbo Yang; C Ming Tse; Varsha Singh; Robert Cole; Peter S Aronson; Hugo de Jonge; Rafiquel Sarker; Mark Donowitz
Journal:  J Biol Chem       Date:  2014-12-05       Impact factor: 5.157

8.  Epsilon subunit-containing acetylcholine receptors in myotubes belong to the slowly degrading population.

Authors:  C Sala; J O'Malley; R Xu; G Fumagalli; M M Salpeter
Journal:  J Neurosci       Date:  1997-12-01       Impact factor: 6.167

9.  Stabilization of acetylcholine receptors by exogenous ATP and its reversal by cAMP and calcium.

Authors:  J P O'Malley; C T Moore; M M Salpeter
Journal:  J Cell Biol       Date:  1997-07-14       Impact factor: 10.539

10.  PKA, PKC, and AKAP localization in and around the neuromuscular junction.

Authors:  G A Perkins; L Wang; L J Huang; K Humphries; V J Yao; M Martone; T J Deerinck; D M Barraclough; J D Violin; D Smith; A Newton; J D Scott; S S Taylor; M H Ellisman
Journal:  BMC Neurosci       Date:  2001-10-23       Impact factor: 3.288

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.